An emerging concept of vascular salt sensitivity

F1000 Biology Reports

Volumn 4, Issue 1, 2012, Pages

  Kusche Vihrog, Kristina ^a   Oberleithner, Hans ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BIOPOLYMER; SODIUM ION;

ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VESSEL PERMEABILITY; ENDOTHELIUM CELL; FUNCTION TEST; GLYCOCALYX; HUMAN; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; RISK ASSESSMENT; SALT PROVOCATION TEST; SODIUM BALANCE; SODIUM BLOOD LEVEL; SODIUM TRANSPORT; VASCULAR SALT SENSITIVITY;

EID: 84868108403     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B4-20     Document Type: Article

References (67)

1. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA: Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005, 85:679-715. (Pubitemid 40404639)
2. MacGregor G: Salt-Neptune's poisoned chalice. Trans Med Soc Lond 2002, 119:13-4.
3. Ritz E: Salt-friend or foe? Nephrol Dial Transplant 2006, 21:2052-6. 4. Guyton AC: Blood pressure control-special role of the kidneys and body fluids. Science 1991, 252:1813-6.
4. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK: Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension 2002, 39:614-8. (Pubitemid 34165193)
5. Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL: Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2004, 43:1252-7. (Pubitemid 38691747)
6. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG: Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003, 63:1791-800. (Pubitemid 36513325)
7. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 1996, 27:481-90. (Pubitemid 26084617)
8. Guyton AC, Coleman TG, Cowley AV, Jr., Scheel KW, Manning RD, Jr., Norman RA, Jr.: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972, 52:584-94.
9. OberleithnerH:Two barriers for sodium in vascular endothelium? Ann Med 2012.
10. Vigne P, Champigny G, Marsault R, Barbry P, Frelin C, Lazdunski M: A new type of amiloride-sensitive cationic channel in endothelial cells of brain microvessels. J Biol Chem 1989, 264:7663-8. (Pubitemid 19119186)
11. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M: Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 2001, 280:1300-6. (Pubitemid 32917785)
12. Wehling M, Spes CH, Win N, Janson CP, Schmidt BM, Theisen K, Christ M: Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998, 83:3517-22. (Pubitemid 28500882)
13. Nguyen Dinh CA, Jaisser F: Extrarenal effects of aldosterone. Curr Opin Nephrol Hypertens 2012, 21:147-56.
14. Schiffrin EL: Effects of aldosterone on the vasculature. Hypertension 2006, 47:312-8. (Pubitemid 43740260)
15. Oberleithner H, Ludwig T, Riethmüller C, Hillebrand U, Albermann L, Schäfer C, Shahin V, Schillers H: Human endothelium: target for aldosterone. Hypertension 2004, 43:952-6. (Pubitemid 38579897)
16. Funder JW: Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology 2006, 147:5564-7. (Pubitemid 44833472)
17. Fels J, Oberleithner H, Kusche-Vihrog K: Menage a trois: aldosterone, sodium and nitric oxide in vascular endothelium. Biochim Biophys Acta 2010, 1802:1193-202.
18. Jeong Y, Chaupin DF, Matsushita K, Yamakuchi M, Cameron SJ, Morrell CN, Lowenstein CJ: Aldosterone activates endothelial exocytosis. Proc Natl Acad Sci U S A 2009, 106:3782-7.
19. Kusche-Vihrog K, Callies C, Fels J, Oberleithner H: The epithelial sodium channel (ENaC): Mediator of the aldosterone response in the vascular endothelium? Steroids 2010, 75:544-9.
20. Pitt B, RemmeW, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction aftermyocardial infarction. N Engl JMed 2003, 348:1309-21.
21. Sanders PW: Vascular consequences of dietary salt intake. Am J Physiol Renal Physiol 2009, 297:F237-43.
22. Briet M, Schiffrin EL: Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol 2010, 6:261-73.
23. Rocha R, Funder JW: The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 2002, 970:89-100. (Pubitemid 35286086)
24. Funder JW: Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone. Hypertension 2006, 47:634-5. (Pubitemid 43740226)
25. Funder JW, Reincke M: Aldosterone: a cardiovascular risk factor? Biochim Biophys Acta 2010, 1802:1188-92.
26. Lang F: Stiff endothelial cell syndrome in vascular inflammation and mineralocorticoid excess. Hypertension 2011, 57:146-7.
27. Waanders F, de Vries LV, van Goor H, Hillebrands JL, Laverman GD, Bakker SJ, Navis G: Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage. Curr Vasc Pharmacol 2011, 9:594-605.
28. Gekle M, Grossmann C: Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch 2009, 458:231-46.
29. Safar ME: Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens 2005, 23:673-81. (Pubitemid 40523260)
30. Duprez D, De Buyzere M, Rietzschel ER, Clement DL: Aldosterone and vascular damage. Curr Hypertens Rep 2000, 2:327-34.
31. Fiebeler A, Muller DN, Shagdarsuren E, Luft FC: Aldosterone, mineralocorticoid receptors, and vascular inflammation. Curr Opin Nephrol Hypertens 2007, 16:134-42.
32. Bussemaker E,Hillebrand U, HausbergM, Pavenstadt H,Oberleithner H: Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone. Am J Kidney Dis 2010, 55:1111-20.
33. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M: Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A 2007, 104:16281-6. (Pubitemid 350099397)
34. Kusche-Vihrog K, Sobczak K, Bangel N, Wilhelmi M, Nechyporuk-Zloy V, Schwab A, Schillers H, Oberleithner H: Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch 2008, 455:849-57. (Pubitemid 350265623)
35. Rossier BC, Canessa CM, Schild L, Horisberger JD: Epithelial sodium channels. Curr Opin Nephrol Hypertens 1994, 3:487-96. (Pubitemid 2138428)
36. Korte S, Wiesinger A, Straeter AS, Peters W, Oberleithner H, Kusche-Vihrog K: Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis. Pflugers Arch 2012, 463:269-78.
37. Li J, White J, Guo L, Zhao X, Wang J, Smart EJ, Li XA: Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 2009, 139:447-51.
38. Friedman SM, McIndoe RA, Tanaka M: The relation of blood sodium concentration to blood pressure in the rat. J Hypertens 1990, 8:61-6. (Pubitemid 20186315)
39. Santos SF, Peixoto AJ: Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 2008, 3:522-30.
40. He FJ, Markandu ND, Sagnella GA, de Wardener HE, MacGregor GA: Plasma sodium: ignored and underestimated. Hypertension 2005, 45:98-102. (Pubitemid 40066421)
41. Suckling RJ, He FJ, Markandu ND, MacGregor GA: Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int 2012, 81:407-11.
42. de Wardener HE: The hypothalamus and hypertension. Physiol Rev 2001, 81:1599-1658. (Pubitemid 32947779)
43. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J, Wier WG: How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 2012, 302:H1031-49.
44. Blaustein MP, Zhang J, Chen L, Song H, Raina H, Kinsey SP, Izuka M, Iwamoto T, Kotlikoff MI, Lingrel JB, Philipson KD,WierWG, Hamlyn JM: The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009, 53:291-8.
45. Becker BF, Chappell D, Jacob M: Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 2010, 105:687-701.
46. Chappell D, Westphal M, Jacob M: The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009, 22:155-62.
47. Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, Tarbell JM: Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 2003, 93:e136-42.
48. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES: The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 2005, 16:507-11. (Pubitemid 41376899)
49. Pries AR, Secomb TW, Gaehtgens P: The endothelial surface layer. Pflugers Arch 2000, 440:653-66.
50. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW: Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007, 18:2885-93. (Pubitemid 350058395)
51. Tarbell JM, Ebong EE: The endothelial glycocalyx: a mechanosensorand -transducer. Sci Signal 2008, 1:t8.
52. Van Teeffelen JW, Brands J, Stroes ES, Vink H: Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc Med 2007, 17:101-5. (Pubitemid 46533936)
53. Weinbaum S, Tarbell JM, Damiano ER: The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007, 9:121-67. (Pubitemid 350246654)
54. Bevan JA: Flow regulation of vascular tone. Its sensitivity to changes in sodium and calcium. Hypertension 1993, 22:273-81. (Pubitemid 23254073)
55. Oberleithner H, Peters W, Kusche-Vihrog K, Korte S, Schillers H, Kliche K, Oberleithner K: Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch 2011, 462:519-28.
56. Siegel G, Walter A, Kauschmann A, Malmsten M, Buddecke E: Anionic biopolymers as blood flow sensors. Biosens Bioelectron 1996, 11:281-94. (Pubitemid 26042805)
57. Siegel G, Malmsten M, Klussendorf D, Walter A, Schnalke F, Kauschmann A: Blood-flow sensing by anionic biopolymers. J Auton Nerv Syst 1996, 57:207-13. (Pubitemid 26098898)
58. Titze J, Lang R, Ilies C, Schwind KH, Kirsch KA, Dietsch P, Luft FC, Hilgers KF: Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol 2003, 285:F1108-17. (Pubitemid 37421047)
59. Titze J, Krause H, Hecht H, Dietsch P, Rittweger J, Lang R, Kirsch KA, Hilgers KF: Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol 2002, 283:F134-41. (Pubitemid 34680480)
60. Kopp C, Linz P, Wachsmuth L, Dahlmann A, Horbach T, Schöfl C, Renz W, Santoro D, Niendorf T, Müller DN, Neininger M, Cavallaro A, Eckardt KU, Schmieder RE, Luft FC, Uder M, Titze J: (23)Na magnetic resonance imaging of tissue sodium. Hypertension 2012, 59:167-72.
61. Titze J, Machnik A: Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 2010, 19:385-92.
62. Titze J: Water-free sodium accumulation. Semin Dial 2009, 22:253-5.
63. Luft FC, Miller JZ, Weinberger MH, Grim CE, Daugherty SA, Christian JC: Influence of genetic variance on sodium sensitivity of blood pressure. Klin Wochenschr 1987, 65:101-9. (Pubitemid 17021646)
64. Luft FC: Molecular genetics of salt-sensitivity and hypertension. Drug Metab Dispos 2001, 29:500-4. (Pubitemid 32275524)
65. Funder JW: The genetic basis of primary aldosteronism. Curr Hypertens Rep 2012, 14:120-4.
66. Funder JW: Relative aldosterone excess: relative to what? Hypertension 2005, 46:643-4. (Pubitemid 43186730)
67. Oberleithner H: A physiological concept unmasking vascular salt sensitivity in man. Pflugers Arch 2012, [Epub ahead of print].